CDK4 and breast carcinoma: At present, we anticipate the results of prospective phase II studies regarding a combination of CDK4/6i treatment and RT in specific breast cancer patients populations: CLEAR trial (NCT03750396), ASPIRE trial (NCT03691493), and PALATINE trial (NCT03870919).